文献速递心胸血管麻醉

6%羟乙基淀粉130/0.4对心脏手术患者炎症反应及肺功能的影响:一项随机临床试验

Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.
PubMed 文献 · Anesth Analg · 2021-01-01

该研究为一项盲法、平行组随机临床试验的子研究,纳入141例择期主动脉瓣置换术患者,比较术中分别使用6% HES 130/0.4或5%人白蛋白进行血浆容量替代对围术期炎症反应和肺功能的影响。结果显示两组炎症标志物(TNF-α、IL-6、MIF)及肺功能参数(Pao2:Fio2比值、动态肺顺应性、氧合指数、通气指数)均无显著差异。

要点

  • 6% HES 130/0.4与5%白蛋白在心脏手术患者中炎症标志物水平无显著差异。
  • 两组肺功能参数包括Pao2:Fio2比值、动态肺顺应性、OI和VI均无显著差异。
  • 研究提示6% HES 130/0.4不加重也不减轻心脏手术后的炎症反应和肺功能损害。

核心结论

  • 心脏手术患者使用6% HES 130/0.4与5%人白蛋白相比,炎症标志物浓度和肺功能指标均无显著差异。

研究设计与样本

  • 盲法、平行组随机临床试验的子研究,在Cleveland Clinic主校区纳入择期主动脉瓣置换术患者。
  • 141例随机接受6% HES 130/0.4或5%人白蛋白进行术中血浆容量替代,135例纳入数据分析(HES组n=66,白蛋白组n=69)。
  • 比较两组基线及术后1小时和24小时的血清TNF-α、IL-6、MIF浓度,以及基线、入ICU 1小时内和拔管前的Pao2:Fio2比值、动态肺顺应性、OI和VI。

主要发现

  • 炎症标志物(TNF-α、IL-6、MIF)血清浓度在两组间无显著差异(P ≥ .05),且估计治疗效应随时间无显著异质性(P ≥ .15)。
  • 肺功能参数(Pao2:Fio2比值、动态肺顺应性、OI、VI)在两组间无显著差异(P ≥ .05),且估计治疗效应随时间无显著异质性(P ≥ .15)。

临床怎么用

  • 对于择期主动脉瓣置换术患者,术中选用6% HES 130/0.4或5%人白蛋白进行血浆容量替代对炎症反应和肺功能影响相似。
  • 临床选择血浆容量替代液时,无需因担忧炎症反应或肺功能影响而优先选择白蛋白而非6% HES 130/0.4。

局限性

  • 本研究为子研究,样本量较小(135例),可能不足以检测微小差异。
  • 研究仅纳入择期主动脉瓣置换术患者,结论外推至其他心脏手术类型需谨慎。
  • 原文未报告炎症标志物和肺功能参数的具体数值及置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac surgery with cardiopulmonary bypass induces a profound inflammatory response that, when severe, can lead to multiorgan system dysfunction. Preliminary data suggest that administration of hydroxyethyl starch (HES) solutions may mitigate an inflammatory response and improve pulmonary function. Our goal was to examine the effect of 6% HES 130/0.4 versus 5% human albumin given for intravascular plasma volume replacement on the perioperative inflammatory response and pulmonary function in patients undergoing cardiac surgery. METHODS: This was a subinvestigation of a blinded, parallel-group, randomized clinical trial of patients undergoing elective aortic valve replacement surgery at the Cleveland Clinic main campus, titled "Effect of 6% Hydroxyethyl Starch 130/0.4 on Kidney and Haemostatic Function in Cardiac Surgical Patients." Of 141 patients who were randomized to receive either 6% HES 130/0.4 or 5% human albumin for intraoperative plasma volume replacement, 135 patients were included in the data analysis (HES n = 66, albumin n = 69). We assessed the cardiopulmonary bypass-induced inflammatory response end points by comparing the 2 groups' serum concentrations of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and macrophage migration inhibitory factor (MIF), measured at baseline and at 1 and 24 hours after surgery. We also compared the 2 groups' postoperative pulmonary function end points, including the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen (Pao2:Fio2 ratio), dynamic lung compliance, oxygenation index (OI), and ventilation index (VI) at baseline, within 1 hour of arrival to the intensive care unit, and before tracheal extubation. The differences in the postoperative levels of inflammatory response and pulmonary function between the HES and albumin groups were assessed individually in linear mixed models. RESULTS: Serum concentrations of the inflammatory markers (TNF-α, IL-6, MIF) were not significantly different (P ≥ .05) between patients who received 6% HES 130/0.4 or 5% albumin, and there was no significant heterogeneity of the estimated treatment effect over time (P ≥ .15). The results of pulmonary function parameters (Pao2:Fio2 ratio, dynamic compliance, OI, VI) were not significantly different (P ≥ .05) between groups, and there was no significant heterogeneity of the estimated treatment effect over time (P ≥ .15). CONCLUSIONS: Our investigation found no significant difference in the concentrations of inflammatory markers and measures of pulmonary function between cardiac surgical patients who received 6% HES 130/0.4 versus 5% albumin.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Lee MJ, Tannenbaum C, Mao G, et al. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial. Anesth Analg. 2021. PMID: 34406128. doi:10.1213/ANE.0000000000005664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。